Información del artículo
El Texto completo está disponible en PDF
Referencias
[1.]
T. Willis.
De Anima Brutorum.
Oxford, (1672), pp. 404-406
[2.]
Pordage Samuel.
The London Pra ctice of Physick.
Ondon, (1683),
[4.]
S. Wilks.
Cerebritis, hysteria and bulbar parálisis as illustrative of arrest of function of the cerebrospinal centres.
Guy's Hospital Report, 22 (1877), pp. 7-55
[5.]
W. Erb.
Zur casuistik der bulbaren lahmungen. (3) Ueber einen neuen, wahrscheinlie bulbaren symptomen complex.
Archiv fur Psychiatrie und Nerven krankheiten, 9 (1879), pp. 336-350
[6.]
H. Openhein.
Ueber einen fall von chrnischer progressive bulbar paralyse ohne anatomischen befund.
Virchows Arch Fur Pathologische Anatomie und Physiolgie, 180 (1887), pp. 522-530
[7.]
C. Eisen lohr.
Ein fall von ophthalmoplegia externa progresssive und finales bulbarparlyse mit negativen sections-befund.
Neurol Centralbl, 6 (1887), pp. 337-390
[8.]
L. Shaw.
A case of bulbar paralysis without structural changes in the medula.
Brain, 13 (1890), pp. 96-98
[9.]
Burdet FM, Fenner F. The production of antibodies. Macmillan (Melbourne) 1949.
[10.]
H.H. Dale, W. Fedlberg, M. Vogt.
Release of acetylcholine at voluntary motor nerendings.
J Physiol, 86 (1936), pp. 353-380
[12.]
A.M. Harvey, R.L. Masland.
The electromyogram in Myasthenia gravis.
Bulletin of the Johns Hopkins Hospital, 69 (1941), pp. 1-13
[13.]
J.A. Simpson, Myasthenia.
Gravis: a new hyphotesis.
Scott Med J, 4 (1960), pp. 419-436
[14.]
J. Patrick, J. Lindstrom.
Autoinmune response to acetylcholina receptor.
Science, 180 (1973), pp. 871-872
[15.]
G. Dighiero.
[Apparently opposite postulates of Ehrlich (Horror autotoxicus) and Metchnikoff (physiological autoimmunization) are not irreconcilable].
Bull Acad Natl Med, 183 (1999), pp. 1153-1163
[16.]
P. Ehrlich, J. Morgenroth.
III Ueber Haemolysine: Zwerte Mittheilung.
Berl. Klin. Wschr, 36 (1900), pp. 481-486
[17.]
P. Ehrlich, J. Morgenroth, F. Mittheilung.
Ueber Haemolysine: Zweite Mittheilung Berl.
Klin Wschr, 36 (1900),
[18.]
P. Del Guercio.
The self and the nonself: Immunorecognition and immunologic functions.
Immunol Res, 12 (1993), pp. 168-182
[19.]
Donath J, Lansteiner K. Donath-Lansteiner antibodies. http://www.whonamedit.com/synd.cfm/3364.html Landsteiner K. http://nobelprize.org/nobel_prizes/medicine/laureates/1930/landsteiner-bio.html.
[20.]
R.S. Schwartz.
Autoimmune folate deficiency and the rise and fall of “Horror autotoxicus”.
N Eng J Med, 352 (2005), pp. 1948-1950
[21.]
A.M. Silverstein.
Autoimmunity versus horror autotoxicus, the struggle for recognition.
Nat Immunol, 2 (2001), pp. 279-281
[22.]
A.M. Silverstein.
The dynamics of conceptual change in twentieth century immunology.
Cell Immunol, 132 (1991), pp. 515-531
[23.]
A.M. Silverstein.
Autoimmunity: A history of the early struggle for recognition.
The autoimmune diseases, 4th, pp. 3-11
[24.]
S. Santucci.
Cittossine. Riv.
Ital Oftal Roma, 2 (1906), pp. 213
[25.]
A. Elsehning.
Studien zur sympatischen ophtalmie Von Graefes.
Arch Ophthalmol, 75 (1910), pp. 459-474
[26.]
A.C. Woods, S. Jomas.
Friedenwald: In Memoriam Bull Johns Hopkins Hosp, 99 (1956), pp. 23
[27.]
A. Patz, S. Jonas.
Friedenwald.
Man of Science. Invest Ophthalmol Vis Sci, 19 (1980), pp. 1139-1149
[28.]
N.R. Rose, E. Witebsky.
Studies on organ specificity V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts.
J Immunol, 76 (1956), pp. 417-427
[29.]
E. Witebsky, N.R. Rose, et al.
Chronic thyroiditis and autoimmunization.
JAMA, 164 (1957), pp. 1439
[30.]
D. Doniach, I. Roitt.
Autoimmunity in Hashimoto's disease and its implications.
J Clin Endocrinol Metab, 17 (1957), pp. 1293
[32.]
A.J. Fulthorpe, I.M. Roitt, D. Doniach, K. Couchman.
A stable sheep cell preparation for detecting thyroglobulin auto-antibodies and its clinical applications.
J Clin Pathol, 14 (1961), pp. 654
[33.]
N.R. Rose.
Current Contents, (1991),
[34.]
Z. Fehervari, S. Sakaguchi.
Regulación de la autoinmunidad.
Invest Ciencia, (2006), pp. 363
[35.]
Mechnikov I. On the present stare of the question of immunity in infectious diseases. Nobel lecture, December 11, 1908. http://nobelprize.org/nobel_prizes/medicine/laureates/1908/mechnikov-lecture.html.
[36.]
T. Addison.
On the constitutional local effects of disease of the supra-renal capsules.
En The real Addison's disease, (1855),
[37.]
A. Jácome.
Historia de las Hormonas.
Academia Nacional de Medicina, (2008),
[38.]
H.E. Takami, et al.
Hashimoto's thyroiditis.
World J Surg, 32 (2008), pp. 688-769
[39.]
Hashimoto H. Zur Kenntnis der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Archiv für klinische Chirurgie, Berlin, 1912; 97:219-248 (citado en www.en.wikipedia.org/wiki/Hashimoto's_thyroiditis).
[40.]
L. De Groot, et al.
Hashimoto's thyroiditis, a genetically conditioned disease.
N Eng J Med, 261 (1962), pp. 267
[41.]
R. Hall, S.G. Owen, G.A. Smart.
Evidence for genetic predisposition to formation of thyroid autoantibodies.
Lancet, 2 (1960), pp. 187
[42.]
C. Betterle, N.A. Greggio, M. Volpato.
Autoimmune polyglandular syndrome type I.
J Clin Endocrinol Metab, 83 (1998), pp. 1049-1055
[43.]
Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002;23:327-364.
[44.]
S.V. Boyden.
Adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemmaglutination by antiprotein sera.
J Exper Med, 93 (1951), pp. 107
[45.]
D. Doniach, R.V. Hudson, I.M. Roitt.
Human autoimmune thyroiditis, clinical studies.
BMJ, 1 (1960), pp. 365
[47.]
I.R. Mackay.
The “Autoimmmune diseases” 4th anniversary.
Autoinmmunity Reviews, 1 (2002), pp. 5-11
[48.]
N.R. Rose.
The discovery of thyroid autoimmunity.
Immunology Today, 12 (1991), pp. 167-169
[49.]
J. Freund, E.R. Stern, T.M. Pisani.
Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and mycobacteria in water in oil emulsion.
J Immunology, 57 (1947), pp. 179-194
[50.]
E. Witebsky.
Die serologische analyse von zellen und geweben.
Die naturwissenschaften, 40 (1929), pp. 771-776
[51.]
N.R. Rose, C. Bona.
Defining criteria for autoimmune diseases (Witebsky's postulates revisited).
Immunol Today, 14 (1993), pp. 426-430
[52.]
E. Witebsky, N.R. Rose, K. Terplan, J.R. Paine, R.W. Egan.
Chronic thyroiditis and autoimmunization.
JAMA, 164 (1957), pp. 1439-1447
[53.]
W.J. Irvine, A.G. McGregor, A.E. Stuart, G.H. Hall.
Hashimoto's disease in uniovular twins.
Lancet, 2 (1961), pp. 850
[54.]
Burnet FM. Immunological recognition of self. Nobel Lecture, December 1960. http://nobelprize.org/nobel_prizes/medicine/laureates/1960/burnetlecture.html.
[55.]
K.L. Becker, R.H. Fergusson, W.M. McConahey.
The connective-tissue diseases and symptoms associated with Hashimoto's thyroiditis.
N Eng J Med, 263 (1963), pp. 277
[56.]
A. Jácome-Roca, A. Mesa Arévalo.
Autoanticuerpos a la tiroglobulina en tiroidopatías.
Univ Med, 6 (1964), pp. 43-50
[57.]
L. Bazzichi, A. Rossi, et al.
Association between thyroid autoimmunity and fibromyalgic disease severity.
Clin Rheumatol, 26 (2007), pp. 2115-2120
[58.]
T.M. Rivers, D.H. Sprunt, G.P. Berry.
Observations on attempts to produce acute disseminated encephalomyelitis in monkeys.
J Exp Med, 58 (1933), pp. 39-54
[59.]
I.R. Mackay, L.I. Taft, D.C. Cowling.
Lupoid hepatitis Lancet, 2 (1956), pp. 1323-1326
[60.]
A. Iglesias-Gamarra.
Historia del Lupus.
1era, Panamericana Formas e impresos, (2003), pp. 405-407
[61.]
M.H. Barker, R.B. Capps, F.W. Allen.
Chronic hepatitis in the Mediterranea theatre.
JAMA, 129 (1943), pp. 653
[62.]
I.J. Wood, W.E. King, P.J. Parsons, et al.
Non-suppurative hepatitis: A study of acute and chronic forms with special reference to biochemical and histological changes.
Med J Aust, 11 (1948), pp. 249
[63.]
J. Waldenstrom, Leber.
Blutproteine und Nahrungseiweiss.
Dtsch Gesellschaft Verdauungs Stoffwechselkrankheiten, 15 (1950), pp. 113
[64.]
H.G. Kunkel, J.R. Ahrens, W.J. Eisenmenger, A.M. Bongiovanni, R.J. Slater.
Extreme hypergammaglobulinemia in young women with liver disease of unknow etiology.
J Clin Invest, 30 (1951), pp. 654
[65.]
I.R. Mackay, B.D. Tait.
The history of autoimmune hepatitis.
Autoinmune hepatitis, pp. 3-23
[66.]
I.R. Mackay, D.C. Gajdusek.
An “autoinmune” reaction against human tissue antigens in certain acute and chronic diseases. II. Clinical correlations.
Arch Intern Med, 101 (1958), pp. 30
[67.]
R.A. Joske, W.E. King.
The LE cell phenomenon in active chronic viral hepatitis.
LANCET, 2 (1955), pp. 477
[68.]
I.R. Mackay, S. Weiden, J. Hasker.
Autoimmune hepatitis.
Ann Ny Acad Sci, 124 (1965), pp. 767
[69.]
A.G. Bearn, H.G. Kunkel, R.J. Slater.
The problem of chronic liver disease in young women.
Am J Med, 21 (1956), pp. 3
[70.]
H. Krook.
Liver cirrhosis in patients with a lupus erythematosus-like syndrome.
Acta Med Scand, 169 (1961), pp. 713
[71.]
M.D. Robson.
Systemic lupus erythematosus complicating chronic liver disease.
Guy's Hosp Rep, 108 (1959), pp. 438
[72.]
J.J. Applebaum, H. Job, F. Kern.
Hepatitis associated with diseminated lupus erythematosus.
Gastroenterology, 40 (1961), pp. 766
[73.]
A.E. Read, S. Sherlock, C.V. Harrison.
Active juvenile cirrhosis as part of a systemic disease and the effect of corticosteroid therapy.
Gut, 4 (1963), pp. 478
[74.]
P.A. Miescher, A. Braveman, E. Amorosi.
Progressive hypergammaglobulinaemic hepatitis.
Dtsch Med Wrschr, 91 (1966), pp. 1525
[75.]
T.B. Reynolds, H.A. Edmondson, R.L. Peters, A. Redeker.
Lupoid hepatitis.
Ann Intern Med, 61 (1964), pp. 650
[76.]
R.D. Soloway, D.M. Summerskill, A.H. Baggenstoss, L.J. Shoenfeld.
“Lupoid” hepatitis, a non-entity in the spectrum of chronic active liver disease.
Gastroenterology, 63 (1975), pp. 458
[77.]
Leevy CM, Popper H, Sherlock S. Diseases of the liver and biliary tract. Standardization of nomenclature, diagnostic criteria and diagnostic methodology. Fogarty International Centre Proceedings No. 22, DHEW Publication No. (NIH) 76-725. U.S. Government Printing Office, Washington DC.
[78.]
I.R. Mackay.
Pathogenesis of autoimmune chronic hepatitis.
Autoimmune liver diseases, pp. 21-42
[79.]
P.J. Johnson, I.G. McFarlane.
Meeting report: International Autoimmune Hepatitis Group.
Hepatology, 18 (1993), pp. 998
[80.]
J.R. Hodges, G.H. Millward Sadler, R. Wright.
Chronic active hepatitis: the spectrum of disease.
Lancet, 1 (1982), pp. 550
[81.]
I.R. Mackay.
Autoimmune diseases of the liver.
The autoimmune diseases, pp. 291-337
[82.]
I.R. Mackay.
Hepatic disease and systemic lupus erythematosus: coincidence or convergence.
Lahita systemic lupus erythematosus, third, pp. 747-763
[83.]
International.
Hepatology Informatics Group. Diseases of the liver and biliary tract.
Standardization of Nomenclature, Diagnostic Criteria and Prognosis, pp. 57-58
[85.]
M. Rizzeto, G. Swana, D. Doniach.
Characterization of the microsomal antigen related to a subclass of active chronic hepatitis.
Immunology, 26 (1974), pp. 589
[86.]
J.C. Homberg, N. Abuaf, O. Bernard, et al.
Chronic active hepatitis with antiliver/kidney microsome antibody type 1: A second type of autoimmune hepatitis.
Hepatology, 7 (1987), pp. 1333
[87.]
I.R. Mackay.
Towards diagnostic criteria for autoimmune hepatitis.
Hepatology, 18 (1993), pp. 1006
[88.]
E. Tonaka, K. Kiyosawa, T. Seki, et al.
Low prevalence of hepatitis C infection in patients with autoimmune hepatitis type I.
J. Gastroenterol Hepatol, 8 (1993), pp. 443
[89.]
G.V. Gregorio, B. Portman, F. Reid, et al.
Autoimmune hepatitis in childhood: a 20 years experience.
Hepatology, 25 (1997), pp. 541
[90.]
D.J. Waxman, D.P. Lapenson, M. Krishnan, et al.
Antibodies to liver /kidney microsome in chronic active hepatitis recognize specific forms of hepatic cytochrome p-450.
Gastroenterology, 95 (1988), pp. 1326
[91.]
M.P. Manns, E.F. Johnson, K.J. Griffen, E.M. Tan, K.F. Sullivan.
Mayor antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome p.450db.
J. Clin Invest, 83 (1989), pp. 1066
[92.]
S.C. Werner.
The Thyroid.
a fundamental an clinical text, Harper Publ, (1955),
[93.]
S.C. Werner, M. Spooner.
A new and simple test for hyperthyroidism employing L-triiodothyronine and the twenty-four hour I-131 uptake method.
Bull. NY Acad Med, 31 (1955), pp. 137-145
[94.]
D.D. Adams, H.D. Purves.
A new method of assay for thyrotropic hormone.
Endocrinology, 57 (1955), pp. 17-24
[95.]
J.M. McKenzie.
The bioassay of thyrotropin in serum.
Endocrinology, 63 (1958), pp. 372-381
[96.]
E. Otero-Ruiz.
La medicina nuclear.
Temprana historia y reminiscencias personales. Ed, Kimpres, (2002),
[97.]
J. Furth, N. Haran-Ghera, P. Oullar.
Induction of thyrotropin dependent thyroid tumors by thyrotropes.
Endocrinology, 66 (1960), pp. 694-701
[98.]
S.C. Werner, E. Otero-Ruiz, B. Seegal, R.W. Bates.
Neutralization of human serum and pituitary thyrotropic fractions with antisera to bovine thyrotropin.
Nature, 185 (1960), pp. 472-473
[99.]
A. Gómez-Gutiérrez.
Investigación médica colombiana.
Acta Med Col, 27 (2002), pp. 441-443
[100.]
S.C. Werner, B.C. Seegal, E.F. Osserman.
Immunologic and biologic characterization of antisera to beef thyrotropin preparations.
J Clin Invest, 40 (1961), pp. 92-104
Copyright © 2009. Asociación Colombiana de Reumatología
